跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.87) 您好!臺灣時間:2026/07/01 16:50
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:李怡儂
研究生(外文):Lee ,Ying-Nung
論文名稱:熱引起SARS-CoV膜蛋白的聚集
論文名稱(外文):Aggregation of SARS-CoV membrane protein induced by heat
指導教授:羅時燕
指導教授(外文):Lo, Shin-Yen
學位類別:碩士
校院名稱:慈濟大學
系所名稱:分子生物及細胞生物研究所
學門:生命科學學門
學類:生物科技學類
論文種類:學術論文
論文出版年:2003
畢業學年度:92
語文別:中文
論文頁數:49
中文關鍵詞:嚴重急性呼吸道症候群膜蛋白蛋白質聚集
外文關鍵詞:SARSmembraneprotein aggregationheat
相關次數:
  • 被引用被引用:0
  • 點閱點閱:277
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
嚴重急性呼吸道症候群是一種新的傳染病,SARS冠狀病毒為導致該病的病原體。在我們實驗室先前的研究中,發現SARS冠狀病毒膜蛋白在變性處理的情況下,不易用西方點墨法偵測到。在本實驗中,我們利用西方點墨法與體外表達蛋白質(同位素標幟)系統,在蛋白質電泳上層膠發現經熱變性(不同加熱溫度,或不同加熱時間)的聚集膜蛋白;因此,我們認為熱會造成SARS-CoV膜蛋白的聚集,使得我們不易在蛋白質電泳下層膠偵測到。為了了解SARS-CoV膜蛋白因熱引起聚集的機制,我們試著用不同的denaturant(SDS、urea、Triton-X100)回溶聚集的SARS-CoV膜蛋白,並發現聚集的膜蛋白不易被回溶。另外,我們也發現膜蛋白疏水性區域:a.a.61-90、a.a.91-100、a.a.136-170對於膜蛋白的聚集是必須的;而且突變的SARS膜蛋白MΔ91-100,會在正常SARS-CoV膜蛋白的存在下發生聚集現象。這似乎意味著SARS-CoV膜蛋白因熱引起的聚集現象,是由於蛋白質疏水性區域分子之間的作用力。 這研究顯示,如果我們要分析SARS-CoV膜蛋白時,應避免一般的加熱步驟;也提供SARS-CoV對熱不穩定現象的可能解釋。SARS-CoV膜蛋白因熱引起的聚集也提供研究蛋白質聚集的一個模式。
Severe acute respiratory syndrome (SARS) is a new respiratory illness caused by the infection of a novel coronavirus called SARS-CoV. Previous studies in our laboratory found that SARS-CoV membrane protein could be easily detected using Western blotting in non-denaturing condition but not in regular denaturing condition. Using Western blotting analysis and in vitro transcription /translation system (isotope-labeled), the aggregated membrane protein with the thermal denaturation (different temperature or different boiling time) was detected in the stacking gel. Therefore, the thermal aggregation of SARS-CoV membrane protein results in the inefficiency in detecting the membrane proteins. The aggregated membrane protein could not be re-dissolved by different denaturants: 2%SDS, 6Murea, 1%Triton-X100 Furthermore, the hydrophobic regions with amino acid residues from 61 to 90, from 91 to 100, and from 136 to 170 are essential for the aggregation of membrane protein. The membrane mutant protein with deletion from a.a.91 to 100 could be aggregated with wild type membrane protein when induced by heat. These results indicate that aggregation of SARS-CoV membrane protein induced by heat is through extensive interaction in hydrophobic domains. Therefore, if SARS-Cov membrane protein needs to be analyzed using SDS-PAGE, regular boiling treatment should be avoiding. Thermal aggregation of SARS-CoV membrane protein may be also responsible for the inactivation of this virus by heat. Thermal aggregation of SARS-CoV membrane protein also provides a model to study the protein aggregation.
目 錄 中文摘要………………………………………………………………………1 英文摘要………………………………………………………………………2 序論………………………………………………………………………………3 實驗材料與方法………………………………………………………………………………8 實驗結果…………………………………………………………………………………….. 17 討論…………………………………………………………………………………………...22 參考文獻……………………………………………………………………………………...25 圖一…………………………………………………………………………………………...30 圖二…………………………………………………………........…………………………...31 圖三……………...……..……………………………………………………………………..32 圖四…………………………………………………………………………………………...33 圖五…………………………………………………..……………………………………….34 圖六…………………………………………………………………………………………...35 圖七…………………………………………………………………….……………………..36 圖八………………………………………………………………….………………………..37 圖九…………………………………………………………………………………………...38 圖十…………………………………………………………………………………………...39 圖十一…………………………………………..…………………………………………….40 圖十二………………………………………………...………………………………………41 圖十三……………………………………..………………………………………………….42 圖十四……………………………………………………...…………………………………43 圖十五…………………………………………………………………………………….…..44 圖十六…………………………………...……………………………………………………...45 圖十七…………………………………………………………………………………………..46 圖十八…………………………………………………………………………………………..47 附錄一…………………………………………………………………………………………..48 附錄二…………………………………………………………………………………………...49
1. Ksiazek T.G,, ERdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J., SARS Working Group. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966. 2. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nichols J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., Yuen K.Y., SARS Study Group. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325. 3. Drosten C., Chiu L.L., Panning M, Leong H.N., Presier W., Tam J.S., Gunther S. Kramme S. Emmerich P., Ng W.L. Schmitz H., Koay E.S. (2004) Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol. 42(5): 2043-2047 4. Huang L.R., Chiu C.M., Yeh S.H., Huang W.H., Hsueh P.R., Yang W.Z., Yang J.Y., Su I.J., Chang S.C., Chen P.J. (2004) Evaluation of antibody responses against SARS coronaviral nucleocaosid or spike proteins by immunobloting or ELISA. J Med Virol. 73(3): 338-346. 5. Xu Y.D., Li Y.M., Liu X.Q., Chen S.B., He W.Q., Xiao Z.L., Zhong N.S. (2003) Clinical therapy of severe acute respiratory syndrome: 38 case retrospective analysis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 15(6): 343-345 6. Tyrrel, D.A. J., J.D. Almedia, D.M. Berry, et al. (1968) Coronavirus. Nature 220:650. 7. Spaan, W., D. Cavanagh, M.C. Horzinek. (1988) Coronaviruses: structure and genome expression. J. Gen. Virol. 69(pt 12): 2939-2952. 8. Sturman, L.S., and K.V. Holmes. 1983. The molecular biology of coronaviruses. Adv. Virus Res. 28:35-112. 9. Bos E.C.W., Luytjes W., van der Meulen H., Koerten H.K., Spaan W.J.M.. (1996) The production of recombinant infectious DI-particle of a murine coronavirus in the absence of helper virus. Virology 218:52-60. 10. Vennema, H., G. J. Godeke, J. W. A. Rossen, W. F. Voorhout, M. C. Horzinek, D. J. E. Opstelten, P.J. M. Rottier. (1996) Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 15:2020-2028. 11. Lai M.M.C. (2003) SARS virus: the beginning of the unraveling of a new coronavirus. J. Biomed. Sci.10: 664-675. 12. Sonia N.M, Weiss S.R. (2003) SARS: lessons learned from other coronaviruses.Viral Immunol. 16:461-474 13. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asaon J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L.. The genome sequence of the SARS-associated coronavirus. (2003) Science 300:1399-1404. 14. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdmann D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399. 15. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J, Poon L.L., Guan Y, Rozanov M., Spaan W.J., Gorbalenya A.E. (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 331(5):991-1004. 16. Zhu G., Chen H.W. (2004) Monophyletic relationship between severe acute respiratory syndrome coronavirus and group 2 coronaviruses. J Infect Dis. 189(9):1676-1678. 17. Gibbs A.J., Gibbs M.J., Armstrong J.S. (2004) The phylogeny of SARS coronavirus. Arch Virol. 149(3):621-624. 18. DE Haan C.A.M., Kuo L.L., Masters P., VenneMa H., Rottier P.J.M. (1998) Coronavirus particle assembly: primary structure requirements of the membrane protein. J. Virol. 72: 6838-6850. 19. Kuo L.L., Masters P.S. (2002) Genetic Evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J. Virol. 76: 4987-4999. 20. Nuemann H., B. Boschek, D. Evans, M. Rosing, T. Tamura, H. D. Klenk. (1982) Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. EMBO J.1:1499-1504. 21. Stern, D. F., B. M. Sefton. (1982) Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins. J. Virol. 44:804-812. 22. Laude, H., J. Gelfi, L. Lavenant, et al. (1992) Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol. 66:743-749. 23. Charley, B., H. Laude. (1988) Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1. J. Virol. 62:8-11. 24. DE Haan C.A.M., de Wit, Kuo L., et al. (2002) O-glycosylation of the mouse hepatitis coronavirus membrane protein. Virus Res. 82:77-81. 25. Fuerst. T. R., E. G. Niles, F. W. Studier, B. Moss. (1986)Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126 26. Lin Y.L., Liao C.L., Chen L.K., Yeh C.T., Liu C.I., Ma S.H., et al. (1998) Study of dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72: 9729-9737. 27. Ma H.C., Ke C.H., Hsieh T.Y., Lo S.Y. (2002) The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein. J Gen Virol.83: 3085-3092. 28. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680-685. 29. Zhao Y, Mine Y, Ma C.Y. (2004) Study of thermal aggregation of oat globulin by laser light scattering. J Agric Food Chem. 52(10): 3089-3096. 30. Abu-Eid M, Kust S.V., Makeeva I.V., Novikov V.K., Dobrov E.N. (1994) Study of the process of thermal aggregation of several representative tobamovirus coat proteins. Mol Gen Mikrobiol Virusol. 3: 28-33. 31. Orlov V.N., Arutyunyan A.M., Kust S.V., Litmanovich E.A., Drachev V.A., Dobrov E.N. (2001) Macroscopic aggregation of tobacco mosaic virus coat protein. Biochemistry (Mosc). 66(2): 154-162 32. Lin H., Zhai J., Canete-Soler R., Schlaepfer W.W. (2004) 3’ untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells. J Neurosci. 24(11): 2716-2726. 33. Tan Y.J., Goh P.Y., Fielding B.C., Shen S., Chou C.F., Fu J.L., Leong H.N., Leo Y.S., Ooi E.E., Ling A.E., Lim S.G., Hong W. (2004) Profile of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin. Diagn. Lab. Immunol. 11(2):362-371 34. Ho Y., Lin P.H., Liu C.Y.Y., Lee S.P., Chao Y.C. (2004) Assembly of human severe acute respiratory syndrome coronavirus-like particles. Biochem Biophys Res Commun. 318:833-838
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文
 
1. 徐剛(1995)• 使用呼吸器有關之合併症•國防醫學,21(4),313-317。
2. 陳星助、林素雲、曾文賓(2000)•全民健保實施論病例計酬支付制度後疾病嚴重度變化情形探討-以臺灣東部某區域醫院外科住院常見疾病為例• 醫院,33(1),32-40。
3. 康翠秀、陳介甫、周碧瑟(1998)• 台北市北投區居民對中醫醫療知識、信念與行為意向及其對醫療行用型態之影響•中華公共衛生雜誌,17(2),80-92。
4. 高振益、謝文斌(1998)• 如何脫離呼吸器•當代醫學,25(4),322-324。
5. 沈建業(1995)•呼吸器的脫離•國防醫學,21(4),317-320
6. 洪維河、鄭守夏、張睿詒、江東亮(1998)• 台灣醫療區跨區住院比例之變遷,1985-1995•中華公共衛生雜誌,17(5),388-394。
7. 陳惠珍、謝文斌(2002)• 長期使用呼吸器病人的照護問題•當代醫學,29(9),753-760。
8. 李琳、姜安波(1995)• 無法手術的實質腫瘤及血液癌病患者使用呼吸器的預後及天數分析•臺灣醫學會雜誌,94(2),s120-s125。
9. 李玉春、林蕙卿(1996)• 全民健康保險支付標準協商模式之檢討改革之芻議•醫院,29(1),1-9。
10. 吳惠東(2005)• 機械呼吸(Mechanical ventilator)•當代醫學,32(3),179-185。
11. 吳就君(1981)• 台灣地區居民社會醫療行為研究•公共衛生,8(1),25-49。
12. 吳清平、楊式興、蔡珮漪、彭萬誠、顏鴻欽、江啟輝(2000)• 在醫學中心內新成立的呼吸器照護中心使用呼吸器患者一年的預後分析•中華民國重症醫學雜誌(Taiwan Crit. Care Med),2(1),1-14。
13. 吳清平(2000)•呼吸器使用之新策略•中華民國重症醫學雜誌(Taiwan Crit. Care Med),2(1),28-34。
14. 余忠仁(1998)• 呼吸衰竭與呼吸治療•當代醫學,25(3),187-194
15. 江玲玲、陳淑如、蔡熒煌、謝文斌(1993)• 長期呼吸器使用的調查研究•長庚醫學期刊,16(2),99-104。